Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Precancerous Conditions D011230 48 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Zanor MI et al. Metabolic characterization of loci affecting sensory attributes in tomato allows an assessment of the influence of the levels of primary metabolites and volatile organic contents. 2009 J. Exp. Bot. pmid:19346240
Kim YH et al. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. 2009 Acta Haematol. pmid:19332985
Lindgren S et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. 2009 Scand. J. Gastroenterol. pmid:19330567
Breborowicz A et al. Intravenous iron sucrose changes the intraperitoneal homeostasis. 2009 Blood Purif. pmid:19325240
Vanin S et al. Seasonal variation of trehalose and glycerol concentrations in winter snow-active insects. 2008 Nov-Dec Cryo Letters pmid:19280052
Muñoz M et al. [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients]. 2009 Med Clin (Barc) pmid:19264195
Clark SF Iron deficiency anemia: diagnosis and management. 2009 Curr. Opin. Gastroenterol. pmid:19262200
Torres-Corzo JG et al. Comparison of cerebrospinal fluid obtained by ventricular endoscopy and by lumbar puncture in patients with hydrocephalus secondary to neurocysticercosis. 2009 Surg Neurol pmid:19249584
Pollak VE et al. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. 2009 BMC Nephrol pmid:19245700
Haddad A et al. Use of iron sucrose in dialysis patients sensitive to iron dextran. 2009 Saudi J Kidney Dis Transpl pmid:19237805
Ibrahim HN et al. Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients. 2009 Clin J Am Soc Nephrol pmid:19211669
Kell DB Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. 2009 BMC Med Genomics pmid:19133145
pmid:19066859
Moon TS et al. Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli. 2009 Appl. Environ. Microbiol. pmid:19060162
Yoon SH et al. Cloning and characterization of uronate dehydrogenases from two pseudomonads and Agrobacterium tumefaciens strain C58. 2009 J. Bacteriol. pmid:19060141
Gonçalves P et al. The effect of high glucose on SERT, the human plasmalemmal serotonin transporter. 2008 Nutr Neurosci pmid:19000377
Bolaños L et al. Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. 2008 Adv Perit Dial pmid:18986009
Young RS Determination of calcium oxide in calcined phosphate ores. 1973 Talanta pmid:18961359
Lord RS and Bralley JA Clinical applications of urinary organic acids. Part I: Detoxification markers. 2008 Altern Med Rev pmid:18950247
pmid:18930421
Yang Z et al. Symbiosis between microorganisms from kombucha and kefir: Potential significance to the enhancement of kombucha function. 2010 Appl. Biochem. Biotechnol. pmid:18810658
pmid:18786076
Stefánsson BV et al. Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection. 2008 Free Radic. Biol. Med. pmid:18775775
Zółtaszek R et al. [The biological role of D-glucaric acid and its derivatives: potential use in medicine]. 2008 Postepy Hig Med Dosw (Online) pmid:18772850
pmid:18727354
pmid:18720044
Oleson L and Court MH Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. 2008 J. Pharm. Pharmacol. pmid:18718121
Anirban G et al. The comparative safety of various intravenous iron preparations in chronic kidney disease patients. 2008 Ren Fail pmid:18661414
Costa S et al. In vitro evaluation of the chemoprotective action mechanisms of leontopodic acid against aflatoxin B1 and deoxynivalenol-induced cell damage. 2009 J Appl Toxicol pmid:18636399
Kaplinsky C Parenteral iron therapy. 2008 Isr. Med. Assoc. J. pmid:18605363
Pinsk V et al. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. 2008 Isr. Med. Assoc. J. pmid:18605353
Auerbach M and Ballard H Intravenous iron in oncology. 2008 J Natl Compr Canc Netw pmid:18597712
Cuenca J et al. Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery. 2008 Anesthesiology pmid:18580186
pmid:18571185
Picker SM et al. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. 2008 Transfusion pmid:18513255
Kuo KL et al. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. 2008 J. Am. Soc. Nephrol. pmid:18495964
Hedenus M and Birgegård G The role of iron supplementation during epoietin treatment for cancer-related anemia. 2009 Med. Oncol. pmid:18473194
Willerson JT Detection of acute myocardial infarcts by infarct-avid imaging. 1991 J. Nucl. Med. pmid:1846912
Usmanov RI et al. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. 2008 Mar-Apr J. Nephrol. pmid:18446719
pmid:18384797
Aghaie A et al. New insights into the alternative D-glucarate degradation pathway. 2008 J. Biol. Chem. pmid:18364348
Auerbach M et al. The role of intravenous iron in anemia management and transfusion avoidance. 2008 Transfusion pmid:18346021
Lim R et al. A permanent tan from iron. 2008 Kidney Int. pmid:18340355
Perek N et al. Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937. 2008 Eur. J. Nucl. Med. Mol. Imaging pmid:18338166
Li H and Wang SX Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. 2008 Mar-Apr Perit Dial Int pmid:18332450
Earley CJ et al. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. 2009 Sleep Med. pmid:18280205
Auerbach M and Al Talib K Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. 2008 Kidney Int. pmid:18274543
Bhatnagar R et al. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate. 1991 Biochem. Pharmacol. pmid:1826840
Jaber BL Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. 2008 Kidney Int. pmid:18235527
Li H and Wang SX Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. 2008 Blood Purif. pmid:18212498